Skip to main content
. 2015 Apr 15;10(4):e0123525. doi: 10.1371/journal.pone.0123525

Table 1. Overview of the substudies with patient numbers.

Flow cytometry qPCR SSP PCR CE SSO + PCR
Retrospective study        
HLA-B*57:01 + n = 23 n = 41 n = 30 n = 41
(n = 41)
Prospective study        
Blinded sampling n = 108 n = 108 n = 96 n = 108
(n = 108)

Representation of the substudies with the amount of samples tested per assay.